HeartMate 3 for Heart Failure with Preserved Ejection Fraction: In Vitro Hemodynamic Evaluation and Anatomical Fitting
Annals of Biomedical Engineering · 2024
DOI: 10.1007/s10439-024-03585-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Biomedical Engineering, 2024. Verfasst von Nina Langer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardio-Respiratory Engineering and Technology Laboratory (CREATElab), Department of Mechanical and Aerospace Engineering, Monash University, Melbourn…. Hauptthemen laut MEDLINE: Heart Failure, Heart-Assist Devices, Stroke Volume, Hemodynamics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Heart Foundation of Australia, National Health and Medical Research Council, Monash University.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure with preserved ejection fraction (HFpEF) constitutes approximately 50% of heart failure (HF) cases, and encompasses different phenotypes. Among these, most patients with HFpEF exhibit structural heart changes, often with smaller left ventricular cavities, which pose challenges for utilizing ventricular assist devices (VADs). A left atrial to aortic (LA-Ao) VAD configuration could address these challenges, potentially enhancing patient quality of life by lowering elevated mean left atrial pressure (MLAP). This study assessed the anatomical compatibility and left atrial unloading capacity using a simulated VAD-supported HFpEF patient. A HeartMate3-supported HFpEF patient in an LA-Ao configuration was simulated using a cardiovascular simulator. Hemodynamic parameters were recorded during rest and exercise at seven pump flow rates. Computed tomography scans of 14 HFpEF (NYHA II–III) and six heart failure with reduced ejection fraction patients were analysed for anatomical comparisons. HFpEF models were independently assessed for virtual anatomical fit with the HM3 in the LA-Ao configuration. Baseline MLAP was reduced from 15 to 11 mmHg with the addition of 1 L/min HM3 support in the rest condition. In an exercise simulation, 6 L/min of HM3 support was required to reduce the MLAP from 29 to 16 mmHg. The HM3 successfully accommodated six HFpEF patients without causing interference with other cardiac structures, whereas it caused impingement ranging from 4 to 14 mm in the remaining patients. This study demonstrated that the HM3 in an LA-Ao configuration may be suitable for unloading the left atrium and relieving pulmonary congestion in some HFpEF patients where size-related limitations can be addressed through pre-surgical anatomical fit analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardio-Respiratory Engineering and Technology Laboratory (CREATElab), Department of Mechanical and Aerospace Engineering, Monash University, Melbourne, VIC, Australia. nina.langer@monash.edu.
- Victorian Heart Institute, Victorian Heart Hospital, Melbourne, VIC, Australia. nina.langer@monash.edu.
- Victorian Heart Hospital, Melbourne, VIC, Australia. nina.langer@monash.edu.
- Cardio-Respiratory Engineering and Technology Laboratory (CREATElab), Department of Mechanical and Aerospace Engineering, Monash University, Melbourne, VIC, Australia.
- Victorian Heart Institute, Victorian Heart Hospital, Melbourne, VIC, Australia.
- School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC, Australia.
Förderung
- National Heart Foundation of Australia
- National Health and Medical Research Council
- Monash University
- Baker Heart and Diabetes Institute
- Alfred Hospital
Zitieren
APA
Langer, N., Stephens, A. F., Šeman, M., McGiffin, D., Kaye, D. M., & Gregory, S. D. (2024). HeartMate 3 for Heart Failure with Preserved Ejection Fraction: In Vitro Hemodynamic Evaluation and Anatomical Fitting. Annals of Biomedical Engineering. https://doi.org/10.1007/s10439-024-03585-y
Vancouver
Langer N, Stephens AF, Šeman M, McGiffin D, Kaye DM, Gregory SD. HeartMate 3 for Heart Failure with Preserved Ejection Fraction: In Vitro Hemodynamic Evaluation and Anatomical Fitting. Annals of Biomedical Engineering. 2024. doi:10.1007/s10439-024-03585-y
BibTeX
@article{Langer2024,
author = {Langer, Nina and Stephens, Andrew F and Šeman, Michael and McGiffin, David and Kaye, David M and Gregory, Shaun D},
title = {HeartMate 3 for Heart Failure with Preserved Ejection Fraction: In Vitro Hemodynamic Evaluation and Anatomical Fitting},
journal = {Annals of Biomedical Engineering},
year = {2024},
doi = {10.1007/s10439-024-03585-y}
}
EUVIMED